{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T19:47:50Z","timestamp":1743450470400},"publisher-location":"Cham","reference-count":38,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319754017"},{"type":"electronic","value":"9783319754024"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-3-319-75402-4_54","type":"book-chapter","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T13:23:42Z","timestamp":1525267422000},"page":"439-445","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Current Pharmacological Concepts in the Treatment of the Retinitis Pigmentosa"],"prefix":"10.1007","author":[{"given":"Xiu-Feng","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,3]]},"reference":[{"key":"54_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1471-2415-6-23","volume":"6","author":"H Bahrami","year":"2006","unstructured":"Bahrami H, Melia M, Dagnelie G (2006) Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial [NCT00029289]. BMC Ophthalmol 6:23","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"54_CR2","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/00006982-198202040-00009","volume":"2","author":"EL Berson","year":"1982","unstructured":"Berson EL (1982) Nutrition and retinal degenerations. Vitamin A, taurine, ornithine, and phytanic acid. Retina 2(4):236\u2013255","journal-title":"Retina"},{"issue":"6","key":"54_CR3","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1001\/archopht.1993.01090060049022","volume":"111","author":"EL Berson","year":"1993","unstructured":"Berson EL, Rosner B, Sandberg MA, Hayes KC, Nicholson BW, Weigel-DiFranco C, Willett W (1993) A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol 111(6):761\u2013772","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"54_CR4","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1001\/archophthalmol.2010.32","volume":"128","author":"EL Berson","year":"2010","unstructured":"Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Brockhurst RJ, Hayes KC, Johnson EJ, Anderson EJ, Johnson CA, Gaudio AR et al (2010) Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A. Arch Ophthalmol 128(4):403\u2013411","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"54_CR5","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1001\/archopht.122.9.1297","volume":"122","author":"EL Berson","year":"2004","unstructured":"Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Moser A, Brockhurst RJ, Hayes KC, Johnson CA, Anderson EJ, Gaudio AR et al (2004a) Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment. Arch Ophthalmol 122(9):1297\u20131305","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"54_CR6","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1001\/archopht.122.9.1306","volume":"122","author":"EL Berson","year":"2004","unstructured":"Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Moser A, Brockhurst RJ, Hayes KC, Johnson CA, Anderson EJ, Gaudio AR et al (2004b) Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses. Arch Ophthalmol 122(9):1306\u20131314","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"54_CR7","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1001\/archophthalmol.2011.2580","volume":"130","author":"EL Berson","year":"2012","unstructured":"Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Willett WC (2012) Omega-3 intake and visual acuity in patients with retinitis pigmentosa receiving vitamin A. Arch Ophthalmol 130(6):707\u2013711","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"54_CR8","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1167\/iovs.09-3903","volume":"51","author":"J Biermann","year":"2010","unstructured":"Biermann J, Grieshaber P, Goebel U, Martin G, Thanos S, Di Giovanni S, Lagreze WA (2010) Valproic acid-mediated neuroprotection and regeneration in injured retinal ganglion cells. Invest Ophthalmol Vis Sci 51(1):526\u2013534","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"54_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1136\/bjo.2009.175356","volume":"95","author":"CM Clemson","year":"2011","unstructured":"Clemson CM, Tzekov R, Krebs M, Checchi JM, Bigelow C, Kaushal S (2011) Therapeutic potential of valproic acid for retinitis pigmentosa. Br J Ophthalmol 95(1):89\u201393","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"54_CR10","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/glia.21155","volume":"59","author":"P Rio Del","year":"2011","unstructured":"Del Rio P, Irmler M, Arango-Gonzalez B, Favor J, Bobe C, Bartsch U, Vecino E, Beckers J, Hauck SM, Ueffing M (2011) GDNF-induced osteopontin from Muller glial cells promotes photoreceptor survival in the Pde6brd1 mouse model of retinal degeneration. Glia 59(5):821\u2013832","journal-title":"Glia"},{"issue":"6288","key":"54_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/347083a0","volume":"347","author":"EG Faktorovich","year":"1990","unstructured":"Faktorovich EG, Steinberg RH, Yasumura D, Matthes MT, LaVail MM (1990) Photoreceptor degeneration in inherited retinal dystrophy delayed by basic fibroblast growth factor. Nature 347(6288):83\u201386","journal-title":"Nature"},{"issue":"11","key":"54_CR12","first-page":"2724","volume":"40","author":"M Frasson","year":"1999","unstructured":"Frasson M, Picaud S, Leveillard T, Simonutti M, Mohand-Said S, Dreyfus H, Hicks D, Sabel J (1999) Glial cell line-derived neurotrophic factor induces histologic and functional protection of rod photoreceptors in the rd\/rd mouse. Invest Ophthalmol Vis Sci 40(11):2724\u20132734","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"54_CR13","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1111\/j.1471-4159.2006.04061.x","volume":"98","author":"OL German","year":"2006","unstructured":"German OL, Insua MF, Gentili C, Rotstein NP, Politi LE (2006) Docosahexaenoic acid prevents apoptosis of retina photoreceptors by activating the ERK\/MAPK pathway. J Neurochem 98(5):1507\u20131520","journal-title":"J Neurochem"},{"issue":"24","key":"54_CR14","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","volume":"20","author":"M Gottlicher","year":"2001","unstructured":"Gottlicher M, Minucci S, Zhu P, Kramer OH, Schimpf A, Giavara S, Sleeman JP, Lo Coco F, Nervi C, Pelicci PG et al (2001) Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 20(24):6969\u20136978","journal-title":"EMBO J"},{"issue":"1","key":"54_CR38","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-1-40","volume":"1","author":"Christian Hamel","year":"2006","unstructured":"Hamel C (2006) Retinitis pigmentosa. Orphanet J Rare Dis 1:40","journal-title":"Orphanet Journal of Rare Diseases"},{"key":"54_CR15","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/S0140-6736(06)69740-7","volume":"368","author":"DT Hartong","year":"2006","unstructured":"Hartong DT, Berson EL, Dryja TP (2006) Retinitis pigmentosa. Lancet 368:1795\u20131809","journal-title":"Lancet"},{"issue":"4","key":"54_CR16","first-page":"704","volume":"137","author":"DR Hoffman","year":"2004","unstructured":"Hoffman DR, Locke KG, Wheaton DH, Fish GE, Spencer R, Birch DG (2004) A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa. Am J Ophthalmol 137(4):704\u2013718","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"54_CR17","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.bbrc.2006.10.072","volume":"351","author":"A Kubota","year":"2006","unstructured":"Kubota A, Nishida K, Nakashima K, Tano Y (2006) Conversion of mammalian Muller glial cells into a neuronal lineage by in vitro aggregate-culture. Biochem Biophys Res Commun 351(2):514\u2013520","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"54_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1006\/mthe.2001.0473","volume":"4","author":"FQ Liang","year":"2001","unstructured":"Liang FQ, Aleman TS, Dejneka NS, Dudus L, Fisher KJ, Maguire AM, Jacobson SG, Bennett J (2001) Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa. Mol Ther 4(5):461\u2013472","journal-title":"Mol Ther"},{"issue":"10","key":"54_CR19","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.1167\/iovs.06-0215","volume":"47","author":"A Maeda","year":"2006","unstructured":"Maeda A, Maeda T, Palczewski K (2006) Improvement in rod and cone function in mouse model of fundus albipunctatus after pharmacologic treatment with 9-cis-retinal. Invest Ophthalmol Vis Sci 47(10):4540\u20134546","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"54_CR20","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1001\/archopht.1993.01090110018004","volume":"111","author":"Michael F. Marmor","year":"1993","unstructured":"Marmor MF (1993) A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol 111(11):1460\u20131461; author reply 1463\u20135","journal-title":"Archives of Ophthalmology"},{"issue":"4","key":"54_CR21","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1001\/archophthalmol.2010.46","volume":"128","author":"RW Massof","year":"2010","unstructured":"Massof RW, Fishman GA (2010) How strong is the evidence that nutritional supplements slow the progression of retinitis pigmentosa? Arch Ophthalmol 128(4):493\u2013495","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"54_CR22","first-page":"216","volume":"42","author":"A Mizota","year":"2001","unstructured":"Mizota A, Sato E, Taniai M, Adachi-Usami E, Nishikawa M (2001) Protective effects of dietary docosahexaenoic acid against kainate-induced retinal degeneration in rats. Invest Ophthalmol Vis Sci 42(1):216\u2013221","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"54_CR23","doi-asserted-by":"publisher","first-page":"3586","DOI":"10.1167\/iovs.08-1735","volume":"49","author":"CT Nguyen","year":"2008","unstructured":"Nguyen CT, Vingrys AJ, Bui BV (2008) Dietary omega-3 fatty acids and ganglion cell function. Invest Ophthalmol Vis Sci 49(8):3586\u20133594","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"54_CR24","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1167\/iovs.07-1470","volume":"49","author":"RA Radu","year":"2008","unstructured":"Radu RA, Yuan Q, Hu J, Peng JH, Lloyd M, Nusinowitz S, Bok D, Travis GH (2008) Accelerated accumulation of lipofuscin pigments in the RPE of a mouse model for ABCA4-mediated retinal dystrophies following Vitamin A supplementation. Invest Ophthalmol Vis Sci 49(9):3821\u20133829","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"54_CR25","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1136\/bjo.2009.167049","volume":"94","author":"Y Rotenstreich","year":"2010","unstructured":"Rotenstreich Y, Harats D, Shaish A, Pras E, Belkin M (2010) Treatment of a retinal dystrophy, fundus albipunctatus, with oral 9-cis-{beta}-carotene. Br J Ophthalmol 94(5):616\u2013621","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"54_CR26","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1046\/j.1471-4159.1997.69020504.x","volume":"69","author":"NP Rotstein","year":"1997","unstructured":"Rotstein NP, Aveldano MI, Barrantes FJ, Roccamo AM, Politi LE (1997) Apoptosis of retinal photoreceptors during development in vitro: protective effect of docosahexaenoic acid. J Neurochem 69(2):504\u2013513","journal-title":"J Neurochem"},{"issue":"4","key":"54_CR27","doi-asserted-by":"publisher","first-page":"276","DOI":"10.2174\/138920211795860062","volume":"12","author":"JN Sahni","year":"2011","unstructured":"Sahni JN, Angi M, Irigoyen C, Semeraro F, Romano MR, Parmeggiani F (2011) Therapeutic challenges to retinitis pigmentosa, from neuroprotection to gene therapy. Curr Genomics 12(4):276\u2013284","journal-title":"Curr Genomics"},{"issue":"5","key":"54_CR28","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1136\/bjo.2010.198176","volume":"95","author":"MA Sandberg","year":"2011","unstructured":"Sandberg MA, Rosner B, Weigel-DiFranco C, Berson EL (2011) Lack of scientific rationale for use of valproic acid for retinitis pigmentosa. Br J Ophthalmol 95(5):744","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"54_CR29","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S0306-9877(03)00198-1","volume":"61","author":"RD Semba","year":"2003","unstructured":"Semba RD, Dagnelie G (2003) Are lutein and zeaxanthin conditionally essential nutrients for eye health? Med Hypotheses 61(4):465\u2013472","journal-title":"Med Hypotheses"},{"issue":"7","key":"54_CR30","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.optm.2008.01.026","volume":"80","author":"K Shintani","year":"2009","unstructured":"Shintani K, Shechtman DL, Gurwood AS (2009) Review and update: current treatment trends for patients with retinitis pigmentosa. Optometry 80(7):384\u2013401","journal-title":"Optometry"},{"issue":"4","key":"54_CR31","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/ajcn\/69.4.656","volume":"69","author":"L Sibulesky","year":"1999","unstructured":"Sibulesky L, Hayes KC, Pronczuk A, Weigel-DiFranco C, Rosner B, Berson EL (1999) Safety of <7500 RE (<25000 IU) vitamin A daily in adults with retinitis pigmentosa. Am J Clin Nutr 69(4):656\u2013663","journal-title":"Am J Clin Nutr"},{"issue":"10","key":"54_CR32","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1073\/pnas.0600236103","volume":"103","author":"PA Sieving","year":"2006","unstructured":"Sieving PA, Caruso RC, Tao W, Coleman HR, Thompson DJ, Fullmer KR, Bush RA (2006) Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. Proc Natl Acad Sci U S A 103(10):3896\u20133901","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"54_CR33","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1136\/bjophthalmol-2012-301950","volume":"96","author":"RA Sisk","year":"2012","unstructured":"Sisk RA (2012) Valproic acid treatment may be harmful in non-dominant forms of retinitis pigmentosa. Br J Ophthalmol 96(8):1154\u20131155","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"54_CR34","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1167\/iovs.10-6479","volume":"52","author":"KE Talcott","year":"2011","unstructured":"Talcott KE, Ratnam K, Sundquist SM, Lucero AS, Lujan BJ, Tao W, Porco TC, Roorda A, Duncan JL (2011) Longitudinal study of cone photoreceptors during retinal degeneration and in response to ciliary neurotrophic factor treatment. Invest Ophthalmol Vis Sci 52(5):2219\u20132226","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"54_CR35","first-page":"3292","volume":"43","author":"W Tao","year":"2002","unstructured":"Tao W, Wen R, Goddard MB, Sherman SD, O'Rourke PJ, Stabila PF, Bell WJ, Dean BJ, Kauper KA, Budz VA et al (2002) Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa. Invest Ophthalmol Vis Sci 43(10):3292\u20133298","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"54_CR36","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1073\/pnas.96.6.3126","volume":"96","author":"Y Uteza","year":"1999","unstructured":"Uteza Y, Rouillot JS, Kobetz A, Marchant D, Pecqueur S, Arnaud E, Prats H, Honiger J, Dufier JL, Abitbol M et al (1999) Intravitreous transplantation of encapsulated fibroblasts secreting the human fibroblast growth factor 2 delays photoreceptor cell degeneration in Royal College of Surgeons rats. Proc Natl Acad Sci U S A 96(6):3126\u20133131","journal-title":"Proc Natl Acad Sci U S A"},{"key":"54_CR37","doi-asserted-by":"crossref","unstructured":"van Schooneveld MJ, van den Born LI, van Genderen M, Bollemeijer JG (2011) The conclusions of Clemson et al concerning valproic acid are premature. Br J Ophthalmol 95(1):153; author reply 153\u20134","DOI":"10.1136\/bjo.2010.194373"}],"container-title":["Advances in Experimental Medicine and Biology","Retinal Degenerative Diseases"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-75402-4_54","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T13:30:53Z","timestamp":1525267853000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-75402-4_54"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783319754017","9783319754024"],"references-count":38,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-75402-4_54","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2018]]}}}